217 related articles for article (PubMed ID: 32513891)
1. Shifting, overlapping and expanding use of "precision oncology" terminology: a retrospective literature analysis.
Tran A; Klossner Q; Crain T; Prasad V
BMJ Open; 2020 Jun; 10(6):e036357. PubMed ID: 32513891
[TBL] [Abstract][Full Text] [Related]
2. Creating a common language: defining individualized, personalized and precision prevention in public health.
Bíró K; Dombrádi V; Jani A; Boruzs K; Gray M
J Public Health (Oxf); 2018 Dec; 40(4):e552-e559. PubMed ID: 29897560
[TBL] [Abstract][Full Text] [Related]
3. From Patient Engagement to Precision Oncology: Leveraging Informatics to Advance Cancer Care.
Griffin AC; Topaloglu U; Davis S; Chung AE
Yearb Med Inform; 2020 Aug; 29(1):235-242. PubMed ID: 32823322
[TBL] [Abstract][Full Text] [Related]
4. Personalized Medicine: Genomics Trials in Oncology.
Hayes DF; Schott AF
Trans Am Clin Climatol Assoc; 2015; 126():133-43. PubMed ID: 26330667
[TBL] [Abstract][Full Text] [Related]
5. Current applications of precision medicine: a bibliometric analysis.
Williams JR; Lorenzo D; Salerno J; Yeh VM; Mitrani VB; Kripalani S
Per Med; 2019 Jul; 16(4):351-359. PubMed ID: 31267841
[TBL] [Abstract][Full Text] [Related]
6. Precision medicine in pediatric oncology.
Forrest SJ; Geoerger B; Janeway KA
Curr Opin Pediatr; 2018 Feb; 30(1):17-24. PubMed ID: 29189430
[TBL] [Abstract][Full Text] [Related]
7. Precision oncology based on omics data: The NCT Heidelberg experience.
Horak P; Klink B; Heining C; Gröschel S; Hutter B; Fröhlich M; Uhrig S; Hübschmann D; Schlesner M; Eils R; Richter D; Pfütze K; Geörg C; Meißburger B; Wolf S; Schulz A; Penzel R; Herpel E; Kirchner M; Lier A; Endris V; Singer S; Schirmacher P; Weichert W; Stenzinger A; Schlenk RF; Schröck E; Brors B; von Kalle C; Glimm H; Fröhling S
Int J Cancer; 2017 Sep; 141(5):877-886. PubMed ID: 28597939
[TBL] [Abstract][Full Text] [Related]
8. Community-driven development of a modified progression-free survival ratio for precision oncology.
Mock A; Heilig CE; Kreutzfeldt S; Huebschmann D; Heining C; Schröck E; Brors B; Stenzinger A; Jäger D; Schlenk R; Glimm H; Fröhling S; Horak P;
ESMO Open; 2019; 4(6):e000583. PubMed ID: 31798980
[TBL] [Abstract][Full Text] [Related]
9. Enabling Precision Oncology Through Precision Diagnostics.
Brown NA; Elenitoba-Johnson KSJ
Annu Rev Pathol; 2020 Jan; 15():97-121. PubMed ID: 31977297
[TBL] [Abstract][Full Text] [Related]
10. New clinical trial designs in the era of precision medicine: An overview of definitions, strengths, weaknesses, and current use in oncology.
Janiaud P; Serghiou S; Ioannidis JPA
Cancer Treat Rev; 2019 Feb; 73():20-30. PubMed ID: 30572165
[TBL] [Abstract][Full Text] [Related]
11. The Pros and Cons of Incorporating Transcriptomics in the Age of Precision Oncology.
Lin VTG; Yang ES
J Natl Cancer Inst; 2019 Oct; 111(10):1016-1022. PubMed ID: 31165154
[TBL] [Abstract][Full Text] [Related]
12. Precision Oncology in Canada: Converting Vision to Reality with Lessons from International Programs.
Liu G; Cheung WY; Feilotter H; Manthorne J; Stockley T; Yeung M; Renouf DJ
Curr Oncol; 2022 Sep; 29(10):7257-7271. PubMed ID: 36290849
[TBL] [Abstract][Full Text] [Related]
13. Definitions and statistical properties of master protocols for personalized medicine in oncology.
Renfro LA; Mandrekar SJ
J Biopharm Stat; 2018; 28(2):217-228. PubMed ID: 28877008
[TBL] [Abstract][Full Text] [Related]
14. Utility of Reverse-Phase Protein Array for Refining Precision Oncology.
Masuda M; Yamada T
Adv Exp Med Biol; 2019; 1188():239-249. PubMed ID: 31820392
[TBL] [Abstract][Full Text] [Related]
15. Path toward Precision Oncology: Review of Targeted Therapy Studies and Tools to Aid in Defining "Actionability" of a Molecular Lesion and Patient Management Support.
Chae YK; Pan AP; Davis AA; Patel SP; Carneiro BA; Kurzrock R; Giles FJ
Mol Cancer Ther; 2017 Dec; 16(12):2645-2655. PubMed ID: 29203694
[TBL] [Abstract][Full Text] [Related]
16. [The new challenge in oncology: Next-generation sequencing and its application in precision medicine].
Calabria I; Pedrola L; Berlanga P; Aparisi MJ; Sánchez-Izquierdo D; Cañete A; Cervera J; Millán JM; Castel V
An Pediatr (Barc); 2016 Nov; 85(5):273.e1-273.e7. PubMed ID: 27349697
[TBL] [Abstract][Full Text] [Related]
17. Precision medicine ethics: selected issues and developments in next-generation sequencing, clinical oncology, and ethics.
Fiore RN; Goodman KW
Curr Opin Oncol; 2016 Jan; 28(1):83-7. PubMed ID: 26569425
[TBL] [Abstract][Full Text] [Related]
18. Next-Generation Sequencing and Result Interpretation in Clinical Oncology: Challenges of Personalized Cancer Therapy.
Khotskaya YB; Mills GB; Mills Shaw KR
Annu Rev Med; 2017 Jan; 68():113-125. PubMed ID: 27813876
[TBL] [Abstract][Full Text] [Related]
19. What is personalized medicine: sharpening a vague term based on a systematic literature review.
Schleidgen S; Klingler C; Bertram T; Rogowski WH; Marckmann G
BMC Med Ethics; 2013 Dec; 14():55. PubMed ID: 24359531
[TBL] [Abstract][Full Text] [Related]
20. The changing face of clinical trials in the personalized medicine and immuno-oncology era: report from the international congress on clinical trials in Oncology & Hemato-Oncology (ICTO 2017).
Golan T; Milella M; Ackerstein A; Berger R
J Exp Clin Cancer Res; 2017 Dec; 36(1):192. PubMed ID: 29282151
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
